Division of Blood and Marrow Transplantation & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
Division of Hematology and Oncology, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
Blood Rev. 2024 Nov;68:101225. doi: 10.1016/j.blre.2024.101225. Epub 2024 Aug 2.
Fanconi anemia (FA) is a rare and complex inherited genetic disorder characterized by impaired DNA repair mechanisms leading to genomic instability. Individuals with FA have increased susceptibility to congenital anomalies, progressive bone marrow failure, leukemia and malignant tumors, endocrinopathies and other medical issues. In recent decades, steadily improved approaches to hematopoietic cell transplantation (HCT), the only proven curative therapy for the hematologic manifestations of FA, have significantly increased the life expectancy of affected individuals, illuminating the need to understand the long-term consequences and multi-organ ramifications. Utilizing a systematized review approach with narrative synthesis of each primary issue and organ system, we shed light on the challenges and opportunities for optimizing the care and quality of life for individuals with FA and identify knowledge gaps informing future research directions.
范可尼贫血症(FA)是一种罕见而复杂的遗传性疾病,其特征是 DNA 修复机制受损,导致基因组不稳定。FA 患者易患先天畸形、进行性骨髓衰竭、白血病和恶性肿瘤、内分泌疾病等其他医学问题。在过去几十年中,造血细胞移植(HCT)的方法不断改进,HCT 是 FA 血液学表现的唯一有效治疗方法,显著提高了受影响个体的预期寿命,凸显了了解长期后果和多器官影响的必要性。我们采用系统评价方法,对每个主要问题和器官系统进行叙述性综合分析,阐明了优化 FA 患者护理和生活质量的挑战和机遇,并确定了未来研究方向的知识空白。